Investigation alert: the gross law firm notifies shareholders of phathom pharmaceuticals, inc. of an investigation and potential class action lawsuit - (nasdaq: phat)

New york , may 26, 2023 /prnewswire/ -- the gross law firm issues the following notice to shareholders of phathom pharmaceuticals, inc.: on august 2, 2022, before market hours, phathom issued a press release entitled "phathom pharmaceuticals reports second quarter 2022 financial results and provides business updates" which announced that "we detected trace levels of a nitrosamine in vonoprazan drug product in our post-approval testing as we prepared for commercial launch." further, the press release announced that "[t]he company is working with the fda and plans to obtain approval of and implement an additional test method, specification, including a proposed acceptable intake limit, and additional controls to address this impurity prior to releasing our first vonoprazan-based products to the market.
NDAQ Ratings Summary
NDAQ Quant Ranking